MAP - Market Access Podcast

Dr. Stefan Walzer

English Business Health & Fitness Medicine Science

Apple Podcasts Spotify Website RSS

Episodes 113

Avg. Duration 34m

Activity Highly Active

Apple Rating ★ 5.0 (1)

Since Sep 2021

Latest Episode Jun 2026

Outreach Signals

Features Guests

Publishing Details

Schedule

Every 2 Weeks

Format

Episodic

Consistency

68%

Hosting

feeds.captivate.fm

About This Podcast

Market Access (or alternatively reimbursement) in health care is THE key competence in order to be commercially successful with a new drug, medical device or digital health application. However, given the fact that market access is a complex field involving various disciplines and is an ever-changing field, it is difficult to be up to speed with the different evolvements across the world. MAP is THE bi-weekly Market Access Podcast provided by MArS Market Access & Pricing Strategy, which is your health care consultancy in the German-speaking markets and allows you to keep up to date with market access , reimbursement and pricing issues in the D-A-CH countries and around the world. With MAP you will get a summary of core market access systems and processes as well as latest changes in regulations including statements and opinions of core decision makers and stakeholders from various countries. The CEO and founder of MArS is also the driver behind MAP: Dr. Stefan Walzer works in the field of payer strategy, pricing, health economics and reimbursement since 2004 and is the founder and CEO of MArS Market Access & Pricing Strategy GmbH based in Germany. MArS makes it as easy as possible for you to get your Pharmaceutical, MedTech or digital health product to the market and of course get the price it deserves. Stefan previously worked as a payer consultant for various global pharmaceutical and medical device / diagnostic companies, successfully launching their products across the world. He was the Global Payer Strategy Leader for various products and compounds at F. Hoffmann – La Roche AG, where he successfully developed early payer strategies as well as launching and maintaining the reimbursement process for top brands and early compounds. Stefan is capable in translating the clinical and economic evidence into successful reimbursement submissions and pricing negotiations especially in Austria, Germany and Switzerland. Additionally he teaches market access, pricing and negotiations at the State University of Baden-Wuerttemberg and the University of Applied Sciences Weingarten-Ravensburg (both Germany). Besides other roles and responsibilities. Stefan was the head of the committee “Inpatient care” of the German Health Economic Association (DGGÖ). Furthermore he is also a member of the Austrian Health Economic Association (ATHEA) and the Swiss Health Economic Association (SGGÖ). Additionally, he is a member of the Access Advisory Committee of the Global Pneumonia Prevention Coalition. Stefan received a Master of Science in Economics from the University of Tuebingen (Germany), a PhD in Health Economics from the University of Zurich (Switzerland) and a post-graduate diploma in Clinical Trials from the London School of Hygiene and Tropical Medicine (UK). He is co-author of more than 40 peer-reviewed scientific articles and more than 300 scientific abstracts.

Podcasting 2.0 Features

episode medium season

Social Media

Explore Statistics

English Podcasts Report Business Report Health & Fitness Report Medicine Report Science Report English Business Report

Recent Episodes

S1E113 Wie finanziert Deutschland Gesundheitsinnovation, ohne den Patientenzugang zu gefährden, Afschin Gandjour?

Jun 08, 2026 36m

In der deutschsprachigen Spezialfolge des MAP – Market Access Podcast spricht Dr. Stefan Walzer mit Prof. Dr. Afschin Gandjour, Arzt, Gesundheitsökonom und Finanzexperte, über eine der zentralen…

S1E112 What lessons can Market Access teams learn from an Olympic medalist, Livia Altmann?

Jun 01, 2026 39m

From Olympic ice to AI-powered leadership: What can Market Access teams learn from elite sports? In the 111+1 anniversary episode of MAP – the Market Access Podcast, Dr. Stefan Walzer interviews…

S1E111 How Are UK NICE and US IRA/MFN Rewriting Global Pharma Pricing, Sreeram Ramagopalan?

May 15, 2026 30m

In the latest episode of MAP – the Market Access Podcast, Dr. Stefan Walzer speaks with Sreeram Ramagopalan, a global expert at the intersection of biotech value, HTA, real‑world evidence and market…

S1E110 How Can Europe Move from Innovation Paradox to Powerhouse, Cuno Moser?

May 01, 2026 38m

In the latest episode of MAP – the Market Access Podcast, Dr. Stefan Walzer engages with Swiss healthcare strategist Cuno Moser to explore Europe's "innovation paradox" in healthcare. Despite its…

S1E109 Are primary research platforms adapting to payer dynamics, Shrutya Bhalla?

Apr 15, 2026 38m

In the latest episode of the MAP – Market Access Podcast, Dr. Stefan Walzer speaks with pricing and access expert Shrutya Bhalla about how primary research must evolve in an era of AI, policy shocks,…

S1E108 How Can Political Leadership Turn Health into an Economic Priority, Hatice Küçük Benton?

Apr 01, 2026 40m

In this episode of the MAP – Market Access Podcast, Dr. Stefan Walzer speaks with Hatice Küçük Beton, Executive Director of the G20 Health and Development Partnership, about how to make global health…

S1E107 Is Europe Still More Attractive Than the US, China, India or MENA for Medtech Investment, Bernard Bichsel?

Mar 15, 2026 34m

In the latest Market Access Podcast episode, host Stefan Walzer sits down with Bernard “Bernie” Bichsel – one of Europe’s most experienced voices in medtech regulation and former Head of the Medical…

S1E106 From Necessary Tasks to New Insights: How Can AI Act as a Sparring Partner in Market Access, Helmut Butscher?

Mar 01, 2026 39m

In this episode, Stefan Walzer talks with experienced Market Access manager Helmut Butscher about concrete AI applications across the full Market Access value chain. They explore how AI accelerates…

S1E105 Can Innovative Contracting Turn High‑Cost Therapies into Sustainable Deals, Omar Ali?

Feb 15, 2026 52m

In this thought‑provoking Market Access Podcast episode, host Stefan Walzer sits down with Omar Ali – Head of Payers at Vipora, former NICE advisor, and one of the sharpest minds in drug pricing and…

S1E104 What Makes Australia’s HTA Approach to Equity and Health Productivity Unique, Zanfina Ademi?

Feb 01, 2026 42m

In this Market Access Podcast episode, Dr. Stefan Walzer sits down with Prof. Zanfania Ademi, a health economist at Monash University, to explore how Australia’s healthcare system is tackling key…

S1E103 No Decisions for Us, Without Us: Why Patient Advocacy Matters in Market Access, Erica Bersin?

Jan 15, 2026 34m

In this episode of the Market Access Podcast, Erica Bersin—founder of ERO Health Communications—joins Dr. Stefan Walzer to discuss the changing role of patient involvement in healthcare. Drawing on…

S1E102 Can VR and AR Finally Break Through the Barriers in Medical Innovation, Günther Illert?

Dec 15, 2025 35m

In this episode of the Market Access Podcast, Dr. Stefan Walzer sits down with strategy consultant and XR advocate Günther Illert to explore how virtual, augmented, and extended reality are reshaping…

S1E101 Why Should Pharma and MedTech Innovators Look at New Zealand, Julius Ohrnberger?

Dec 01, 2025 38m

Tune in to this new episode of MAP to explore New Zealand’s unique healthcare and reimbursement landscape with Dr. Stefan Walzer and health economist Dr. Julius Ohnberger. Learn how PHARMAC combines…

S1E100 Are We Ready for a Cultural Shift Toward AI in Pharma, Elizabeth Shanahan?

Nov 15, 2025 37m

In this brand new episode of MAP - the Market Access Podcast, Dr. Stefan Walzer sits down with Elizabeth Shanahan, AI Strategy Lead at Sanofi, for a refreshingly honest conversation on the real-world…

S1E99 What Can Europe and the U.S. Learn from Each Other on Market Access, Anne Loos?

Nov 01, 2025 27m

Tune in to this new episode of MAP, the Market Access Podcast, where Dr. Stefan Walzer is joined by Anne Loos from Wickenstones, to explore the evolving landscape of U.S. market access and…

S1E98 Will AI and Living Reviews Define the Next Era of Health Policy, Anna Forsythe?

Oct 15, 2025 29m

Join this episode of MAP – The Market Access Podcast as Dr. Stefan Walzer sits down with Anna Forsythe, founder of OncoScope-AI, to explore how Living Systematic Literature Reviews (Living SLRs) are…

S1E97 Are We Undervaluing the Economic Power of Health, Dr. Malina Müller?

Oct 01, 2025 38m

In the latest MAP Podcast, our host Dr. Stefan Walzer is joined by Dr. Malina Müller from the WifOR Institute to rethink how we value health. From real-world ROI data to policy shifts and long-term…

S1E96 How Should Pharma Respond to the New Reality of Market Access in Germany, Prof. Dr. Thomas Hammerschmidt?

Sep 15, 2025 34m

In this episode of MAP - the Market Access Podcast, Dr. Stefan Walzer sits down with expert Prof. Dr. Thomas Hammerschmidt, to dive deep into Germany’s evolving AMNOG framework and what it really…

S1E95 Do Swiss Reimbursement Reforms Open Doors—or Raise New Barriers, Petra Erni?

Sep 01, 2025 29m

Tune in to this episode of MAP – The Market Access Podcast, to hear from Dr. Stefan Walzer as he speaks with Swiss reimbursement expert Petra Erni, who brings a rare perspective from both the…

S1E94 The Startup Guide to Navigating Healthcare Reimbursement, Featuring Ron de Graaff (Repost)

Aug 15, 2025 33m

This is a repost of a popular episode of MAP - Market Access Podcast, from December 1st 2023.We are thrilled to announce our latest podcast episode, featuring a riveting conversation between our CEO…

Frequently Asked Questions

How many episodes does MAP - Market Access Podcast have?

MAP - Market Access Podcast has published 113 episodes since September 2021, covering topics in Business, Health & Fitness.

Is MAP - Market Access Podcast still active?

MAP - Market Access Podcast is currently highly active with new episodes every 2 weeks. Average episode length is 34m.